Table 2.
Parameter | N=36 (%) |
---|---|
Primary disorder | |
Acute Myeloid Leukemia | 17 (47) |
Chronic Lymphoid Leukemia | 6 (17) |
Acute Lymphoid Leukemia | 4 (11) |
Non-Hodgkin’s Lymphoma | 5 (14) |
Chronic Myeloid Leukemia | 2 (5.5) |
Myelodysplastic syndrome | 2 (5.5) |
Conditioning regimen | |
Total body irradiation + Chemotherapy | 16 (44) |
Chemotherapy alone | 20 (56) |
Systemic graft-versus-host disease | |
Skin | 26 (72) |
Mouth | 25 (69) |
Liver | 13 (36) |
Gastrointestinal tract | 7 (19) |
Lung | 3 (8) |